Tokyo, Japan, April 1, 2025 – Azuriris, Inc. (“Azuriris”), a private biotechnology company, today announces its official establishment in Shinjuku, Tokyo, Japan. “We’re thrilled to share this exciting news,” said Yusuke Tominari, Ph.D., Co-Founder and CEO of Azuriris. “At Azuriris, we are building a future where science and imagination converge to improve health and well-being for people around the world”.
###
Media and Investor Contact:
Azuriris, Inc.
7F/8F, Nishi-Shinjuku Takagi Building
1-20-3, Nishi-Shinjuku, Shinjuku, Tokyo 160-0023, Japan
E-mail：info@azuriris.com
